Customer Q&A: Novartis

Novartis has a rich history of investing in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs. As the industry faces acute disruption, the company’s prescription for ongoing success hinges on APIs and microservices. Pascal Bouquet, Global Head of Architecture for Drug Development, answers a few questions about how digital transformation is moving Novartis forward.  

Previous Asset
Is API complexity holding you back?
Is API complexity holding you back?

Break free with centralized API visibility, control, and reuse across multiple vendors, gateways, and clouds

Next Asset
Digital transformation survival guide Part 4
Digital transformation survival guide Part 4

The future is open: create your digital destiny by giving teams a central place to unlock the business valu...


Get the full Forrester Opportunity Snapshot: Closing the Gap between API Development and API Consumption

First Name
Last Name
Job Title
By submitting this form, you confirm that you agree to the processing of your personal data by Axway as described in our privacy notice. Axway will process your personal information for carefully considered and specific purposes that are in our interests and enable us to enhance the services we provide, but which we believe also for your benefit. You acknowledge that we may transfer your profile information to Axway legal entities and our service providers for administrative purposes only. Please note that if you no longer wish to receive our emails you may update your email preferences at any time.
Thank you!
Error - something went wrong!